CP-25 exhibits therapeutic efficacy against kidney injury in DKD. Its primary mechanism involves modulating the differentiation and function of DCs, which affects the activation of T cells. In terms of mechanism, CP-25 targets the GRK2-mediated JAK2-STAT3-SOCS3 signalling pathway to inhibit inflammation for alleviating DKD.
Building similarity graph...
Analyzing shared references across papers
Loading...
Liang et al. (Wed,) studied this question.
synapsesocial.com/papers/69df2ba0e4eeef8a2a6b08ed — DOI: https://doi.org/10.1111/1440-1681.70124
Wei Liang
Anhui University of Traditional Chinese Medicine
Dongchun Zhu
Anhui University of Traditional Chinese Medicine
Lei Xiao
Anhui University of Traditional Chinese Medicine
Clinical and Experimental Pharmacology and Physiology
Chinese University of Hong Kong
Anhui Medical University
Huadong Hospital
Building similarity graph...
Analyzing shared references across papers
Loading...
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: